New Principles and Adequate Robust Control Methods for Artificial Pancreas

The current work is a short review of the research results obtained by the Biomedical Engineering laboratory of the Control Engineering and Information Technology Department, Budapest University of Technology and Economics (BME) in the field of automatic control of Type I diabetes mellitus, and mainly is focused on the PhD dissertation written by the first author [1]. The topic focuses on modeling formalisms and implementation of robust control algorithms for optimal insulin dosage in case of Type I diabetes patients. Regarding modelling concepts, an extension of the modified Bergman minimal model, the analytical investigation of the high complexity Sorensen-model and model synthesis of a novel molecular-based model are described. From robust control methods implementation firstly, the minimax method is applied and is described that its limitations can be spanned using Grobner basis. Secondly, the graphical interpretation of the H inf method under Mathematica program is extended with disturbance rejection criteria. Thirdly, an LPV (Linear Parameter Varying) type robust control method is described for the high complexity Sorensen-model; hence it is possible to deal directly with the non-linear model itself. Finally, actual research tasks are summarized related to the previously mentioned topics and further research directions are formulated.

[1]  Francis J. Doyle,et al.  Glucose control design using nonlinearity assessment techniques , 2005 .

[2]  Francis J. Doyle,et al.  Robust H∞ glucose control in diabetes using a physiological model , 2000 .

[3]  Levente Kovács,et al.  Analyzing a novel model of human blood glucose system at molecular levels , 2009, 2009 European Control Conference (ECC).

[4]  John Thomas Sorensen,et al.  A physiologic model of glucose metabolism in man and its use to design and assess improved insulin therapies for diabetes , 1985 .

[5]  Ricardo Femat,et al.  Blood glucose control for type I diabetes mellitus: A robust tracking H∞ problem , 2004 .

[6]  D. Dazzi,et al.  The control of blood glucose in the critical diabetic patient: a neuro-fuzzy method. , 2001, Journal of diabetes and its complications.

[7]  Levente Kovács,et al.  Induced L2-norm minimization of glucose-insulin system for Type I diabetic patients , 2011, Comput. Methods Programs Biomed..

[8]  R. Hovorka,et al.  Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. , 2004, Physiological measurement.

[9]  Roman Hovorka Management of diabetes using adaptive control , 2005 .

[10]  Z. Benyo,et al.  Robust Blood-Glucose Control using Mathematica , 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.

[11]  M. Morari,et al.  Closed-Loop Control of Blood Glucose , 2007 .

[12]  Levente Kovács,et al.  Robust and Optimal Blood-Glucose Control in Diabetes Using Linear Parameter Varying paradigms , 2009 .

[13]  R. Hovorka,et al.  Partitioning glucose distribution/transport, disposal, and endogenous production during IVGTT. , 2002, American journal of physiology. Endocrinology and metabolism.

[14]  R S Parker,et al.  The intravenous route to blood glucose control. , 2001, IEEE engineering in medicine and biology magazine : the quarterly magazine of the Engineering in Medicine & Biology Society.

[15]  Levente Kovács,et al.  Glucose-Insulin Control of Type1 Diabetic Patients in H2/Hinfinity Space Via Computer Algebra , 2007, AB.

[16]  Ovide Arino,et al.  Mathematical modelling of the intravenous glucose tolerance test , 2000, Journal of mathematical biology.

[17]  Levente Kovács,et al.  LPV modeling of type 1 diabetes mellitus , 2007 .

[18]  J. William Helton,et al.  Classical Control Using H∞ Methods: Theory, Optimization, and Design , 1998 .

[19]  Levente Kovács,et al.  Robust Blood-Glucose Control of Type I Diabetes Patients Under Intensive Care Using Mathematica , 2008 .

[20]  Robert S. Parker,et al.  Mixed Meal Modeling and Disturbance Rejection in Type I Diabetic Patients , 2006, 2006 International Conference of the IEEE Engineering in Medicine and Biology Society.

[21]  B. Paláncz,et al.  Robust control techniques and its graphical representation in case of Type I diabetes using Mathematica , 2010, 2010 IEEE 8th International Symposium on Applied Machine Intelligence and Informatics (SAMI).

[22]  F. Chee,et al.  Expert PID control system for blood glucose control in critically ill patients , 2003, IEEE Transactions on Information Technology in Biomedicine.

[23]  Z. Benyo,et al.  LPV fault detection of glucose-insulin system , 2006, 2006 14th Mediterranean Conference on Control and Automation.

[24]  R. Bergman,et al.  Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. , 1981, The Journal of clinical investigation.

[25]  D. Streja,et al.  A new biphasic minimal model , 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[26]  J. Doyle,et al.  Robust and optimal control , 1995, Proceedings of 35th IEEE Conference on Decision and Control.

[27]  Claudio Cobelli,et al.  Meal Simulation Model of the Glucose-Insulin System , 2007, IEEE Transactions on Biomedical Engineering.

[28]  S. Wild,et al.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. , 2004, Diabetes care.

[29]  Y. Z. Ider,et al.  Quantitative estimation of insulin sensitivity. , 1979, The American journal of physiology.

[30]  M. Fernandez,et al.  Enhancing parameter precision and the minimal modeling approach in type I diabetes , 2004, The 26th Annual International Conference of the IEEE Engineering in Medicine and Biology Society.

[31]  Fusheng Tang,et al.  Modeling a simplified regulatory system of blood glucose at molecular levels. , 2008, Journal of theoretical biology.

[32]  Robert S Parker,et al.  Dynamic modeling of free fatty acid, glucose, and insulin: an extended "minimal model". , 2006, Diabetes technology & therapeutics.